Pharming Group NV News - PHAR | Aktien NASDAQ

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Pharming Group to report second quarter and first half 2023 financial results on August 3

Pharming Group to report second quarter and first half 2023 financial results on August 3 PR Newswire LEIDEN...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 6-KREPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR...

Pharming announces sale of priority review voucher

Pharming announces sale of priority review voucher PR Newswire LEIDEN, The Netherlands, June 1, 2023 LEIDEN...

Pharming Group to attend the following Investor Conferences in June

Pharming Group to attend the following Investor Conferences in June PR Newswire LEIDEN, The Netherlands, May...

Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders

Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders PR Newswire LEIDEN, The Netherlands, May 17, 2023 LEIDEN...

Pharming Group reports financial results for the first quarter of 2023

Pharming Group reports financial results for the first quarter of 2023 PR Newswire LEIDEN, Netherlands, May...

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023 PR Newswire LEIDEN, Netherlands...

Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023

Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023 PR Newswire LEIDEN, Netherlands...

Notice of First Quarter 2023 Results

Notice of First Quarter 2023 Results PR Newswire LEIDEN, Netherlands, April 19, 2023 LEIDEN, Netherlands...

Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023

Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023 PR Newswire LEIDEN...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 6-KREPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR...

1
2
Weiter

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Pharming Group NV (PHAR)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

PHAR Nachrichten

Pharming Group to report second quarter and first half 2023 financial results on August 3

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Pharming announces sale of priority review voucher

Pharming Group to attend the following Investor Conferences in June

Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders

Pharming Group reports financial results for the first quarter of 2023

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023

Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023

Notice of First Quarter 2023 Results

Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

PHAR Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Pharming Group NV (PHAR) News

Pharming Group NV (PHAR)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

PHAR Nachrichten

Pharming Group to report second quarter and first half 2023 financial results on August 3

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Pharming announces sale of priority review voucher

Pharming Group to attend the following Investor Conferences in June

Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders

Pharming Group reports financial results for the first quarter of 2023

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023

Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023

Notice of First Quarter 2023 Results

Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

PHAR Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen